Berg M

References (3)

Title : In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time - Verhulst_2026_Eur.J.Med.Chem_304_118494
Author(s) : Verhulst E , Brzeminski P , de Groot A , Wals JW , Michiels R , Fabisiak A , Thys J , Grintsevich S , Van Rymenant Y , Peeters S , Lambregts S , Sim Y , Verstraete R , Van Wielendaele P , Berg M , Elvas F , Van Ostade X , Rosch F , Lambeir AM , De Winter H , Van der Veken P , De Meester I
Ref : Eur Journal of Medicinal Chemistry , 304 :118494 , 2026
Abstract :
PubMedSearch : Verhulst_2026_Eur.J.Med.Chem_304_118494
PubMedID: 41455278
Gene_locus related to this paper: human-FAP

Title : Structure-Property Investigation of New KetoFAPI Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential - Brzeminski_2025_J.Med.Chem_68_21739
Author(s) : Brzeminski P , Verhulst E , Fabisiak A , Pacifico R , Willocx D , Peeters S , de Groot A , Corthaut S , Van Meel K , Stroobants S , Augustyns K , Berg M , Lambeir AM , Rosch F , De Meester I , Elvas F , Van der Veken P
Ref : Journal of Medicinal Chemistry , 68 :21739 , 2025
Abstract :
PubMedSearch : Brzeminski_2025_J.Med.Chem_68_21739
PubMedID: 41086263
Gene_locus related to this paper: human-FAP

Title : Rivastigmine as an alternative treatment for anticholinergic toxidrome in light of the physostigmine shortage: A case series - Berg_2025_Am.J.Emerg.Med_94_144
Author(s) : Berg M , Strand A , Garrett ND , Keric A , Wilkinson J
Ref : Am J Emerg Med , 94 :144 , 2025
Abstract :
PubMedSearch : Berg_2025_Am.J.Emerg.Med_94_144
PubMedID: 40288328